Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Everolimus and Capecitabine in Patients With Advanced Malignancy (m-TOR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2008 by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
ClinicalTrials.gov Identifier:
NCT01079702
First received: March 2, 2010
Last updated: NA
Last verified: January 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2011
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)